血液科指南

订阅

MedSci主页 / 所有栏目 / 血液科指南

《中国成人急性淋巴细胞白血病诊断与治疗指南（2021年版）》——Ph阳性急性淋巴细胞白血病治疗的解读与思考

2022-03-01 国家血液系统疾病临床医学研究中心北京大学血液病研究所北京大学人民医院 临床血液学杂志

急性淋巴细胞白血病

在过去的20年里，Ph阳性急性淋巴细胞白血病（Ph-positive acute lymphoblastic leukemia, Ph+ALL）的治疗结局得到显著改善。伊马替尼的问世，使Ph+ALL患

中文标题：

《中国成人急性淋巴细胞白血病诊断与治疗指南（2021年版）》——Ph阳性急性淋巴细胞白血病治疗的解读与思考

发布机构：

国家血液系统疾病临床医学研究中心北京大学血液病研究所北京大学人民医院

发布日期：

2022-03-01

简要介绍：

在过去的20年里，Ph阳性急性淋巴细胞白血病（Ph-positive acute lymphoblastic leukemia, Ph+ALL）的治疗结局得到显著改善。伊马替尼的问世，使Ph+ALL患者的完全缓解（complete remission, CR）率高达95%以上，35%～45%的患者可获得长期生存[1]。

相关资料下载：
[AttachmentFileName(sort=1, fileName=《中国成人急性淋巴细胞白血病诊断与治疗指南（2021年版）》——Ph阳性急性淋巴细胞白血病治疗的解读与思考.pdf)] GetToolGuiderByIdResponse(projectId=1, id=2ef331c002a339de, title=《中国成人急性淋巴细胞白血病诊断与治疗指南（2021年版）》——Ph阳性急性淋巴细胞白血病治疗的解读与思考, enTitle=, guiderFrom=临床血液学杂志, authorId=0, author=, summary=在过去的20年里，Ph阳性急性淋巴细胞白血病（Ph-positive acute lymphoblastic leukemia, Ph+ALL）的治疗结局得到显著改善。伊马替尼的问世，使Ph+ALL患, cover=https://img.medsci.cn/20220510/1652159351821_5579292.jpg, journalId=0, articlesId=null, associationId=2703, associationName=国家血液系统疾病临床医学研究中心北京大学血液病研究所北京大学人民医院, associationIntro=国家血液系统疾病临床医学研究中心北京大学血液病研究所北京大学人民医院, copyright=0, guiderPublishedTime=Tue Mar 01 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #666666;">在过去的20年里，Ph阳性急性淋巴细胞白血病（Ph-positive acute lymphoblastic leukemia, Ph+ALL）的治疗结局得到显著改善。伊马替尼的问世，使Ph+ALL患者的完全缓解（complete remission, CR）率高达95%以上，35%～45%的患者可获得长期生存</span><sup style="color: #666666;">[1]</sup><span style="color: #666666;">。</span></p>, tagList=[TagDto(tagId=1425, tagName=急性淋巴细胞白血病)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4521, appHits=254, showAppHits=0, pcHits=590, showPcHits=4267, likes=1, shares=43, comments=6, approvalStatus=1, publishedTime=Tue May 10 15:07:00 CST 2022, publishedTimeString=2022-03-01, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Tue May 10 13:10:58 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 07:17:18 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=《中国成人急性淋巴细胞白血病诊断与治疗指南（2021年版）》——Ph阳性急性淋巴细胞白血病治疗的解读与思考.pdf)])
《中国成人急性淋巴细胞白血病诊断与治疗指南（2021年版）》——Ph阳性急性淋巴细胞白血病治疗的解读与思考.pdf
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1236163, encodeId=d1b2123616359, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49b48108998, createdName=ms3000000782693035, createdTime=Tue Aug 02 15:48:13 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218527, encodeId=0930121852e01, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e556504447, createdName=ms9000002138466017, createdTime=Tue May 10 19:22:22 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220413, encodeId=0420122041313, content=<a href='/topic/show?id=994952328d2' target=_blank style='color:#2F92EE;'>#急性淋巴细胞白血病#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52328, encryptionId=994952328d2, topicName=急性淋巴细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Tue May 17 16:42:00 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218531, encodeId=35d81218531c9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e556504447, createdName=ms9000002138466017, createdTime=Tue May 10 19:23:43 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218528, encodeId=2d6412185281f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e556504447, createdName=ms9000002138466017, createdTime=Tue May 10 19:22:32 CST 2022, time=2022-05-10, status=1, ipAttribution=)]
    2022-08-02 ms3000000782693035

    赞

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1236163, encodeId=d1b2123616359, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49b48108998, createdName=ms3000000782693035, createdTime=Tue Aug 02 15:48:13 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218527, encodeId=0930121852e01, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e556504447, createdName=ms9000002138466017, createdTime=Tue May 10 19:22:22 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220413, encodeId=0420122041313, content=<a href='/topic/show?id=994952328d2' target=_blank style='color:#2F92EE;'>#急性淋巴细胞白血病#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52328, encryptionId=994952328d2, topicName=急性淋巴细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Tue May 17 16:42:00 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218531, encodeId=35d81218531c9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e556504447, createdName=ms9000002138466017, createdTime=Tue May 10 19:23:43 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218528, encodeId=2d6412185281f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e556504447, createdName=ms9000002138466017, createdTime=Tue May 10 19:22:32 CST 2022, time=2022-05-10, status=1, ipAttribution=)]
    2022-05-10 ms9000002138466017

    学习

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1236163, encodeId=d1b2123616359, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49b48108998, createdName=ms3000000782693035, createdTime=Tue Aug 02 15:48:13 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218527, encodeId=0930121852e01, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e556504447, createdName=ms9000002138466017, createdTime=Tue May 10 19:22:22 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220413, encodeId=0420122041313, content=<a href='/topic/show?id=994952328d2' target=_blank style='color:#2F92EE;'>#急性淋巴细胞白血病#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52328, encryptionId=994952328d2, topicName=急性淋巴细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Tue May 17 16:42:00 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218531, encodeId=35d81218531c9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e556504447, createdName=ms9000002138466017, createdTime=Tue May 10 19:23:43 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218528, encodeId=2d6412185281f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e556504447, createdName=ms9000002138466017, createdTime=Tue May 10 19:22:32 CST 2022, time=2022-05-10, status=1, ipAttribution=)]
    2022-05-17 赛华佗

    #急性淋巴细胞白血病#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1236163, encodeId=d1b2123616359, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49b48108998, createdName=ms3000000782693035, createdTime=Tue Aug 02 15:48:13 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218527, encodeId=0930121852e01, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e556504447, createdName=ms9000002138466017, createdTime=Tue May 10 19:22:22 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220413, encodeId=0420122041313, content=<a href='/topic/show?id=994952328d2' target=_blank style='color:#2F92EE;'>#急性淋巴细胞白血病#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52328, encryptionId=994952328d2, topicName=急性淋巴细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Tue May 17 16:42:00 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218531, encodeId=35d81218531c9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e556504447, createdName=ms9000002138466017, createdTime=Tue May 10 19:23:43 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218528, encodeId=2d6412185281f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e556504447, createdName=ms9000002138466017, createdTime=Tue May 10 19:22:32 CST 2022, time=2022-05-10, status=1, ipAttribution=)]
    2022-05-10 ms9000002138466017

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1236163, encodeId=d1b2123616359, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49b48108998, createdName=ms3000000782693035, createdTime=Tue Aug 02 15:48:13 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218527, encodeId=0930121852e01, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e556504447, createdName=ms9000002138466017, createdTime=Tue May 10 19:22:22 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220413, encodeId=0420122041313, content=<a href='/topic/show?id=994952328d2' target=_blank style='color:#2F92EE;'>#急性淋巴细胞白血病#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52328, encryptionId=994952328d2, topicName=急性淋巴细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Tue May 17 16:42:00 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218531, encodeId=35d81218531c9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e556504447, createdName=ms9000002138466017, createdTime=Tue May 10 19:23:43 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218528, encodeId=2d6412185281f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e556504447, createdName=ms9000002138466017, createdTime=Tue May 10 19:22:32 CST 2022, time=2022-05-10, status=1, ipAttribution=)]
    2022-05-10 ms9000002138466017

    学习

    0

相关指南

抗急性淋巴细胞白血病药物临床试验中检测微小残留病的技术指导原则（征求意见稿）

国家药品监督管理局药品审评中心（CDE） · 2020-06-01

第二代基因测序技术用于成年费城染色体阳性急性淋巴细胞白血病患者BCR‑ABL1激酶结构域突变检测

国外血液科相关专家小组 · 2020-05-20

2018 JSH实践指南：血液恶性肿瘤—Ⅰ.白血病-3.急性淋巴细胞白血病／成淋巴细胞白血病

日本血液学会(JSH,Japanese Society of Hematology) · 2020-08-18

2018 北美专家共识建议：成人急性淋巴细胞白血病可测量残留病评估和管理

国外血液科相关专家小组 · 2018-11-05

2018 EWALL/EBMT立场声明：造血干细胞移植治疗成人费城染色体阴性急性淋巴细胞白血病首次缓解

欧洲血液和骨髓移植小组(EBMT,European Group for Blood and Marrow Transplantation) · 2018-11-01